tradingkey.logo
tradingkey.logo
Pesquisar

Artivion Inc

AORT
Adicionar à lista de desejos
23.970USD
+0.420+1.78%
Fechamento 07/02, 13:00ETCotações atrasadas em 15 min
1.16BValor de mercado
93.41P/L TTM

Mais detalhes de Artivion Inc Empresa

Artivion, Inc. is a medical device company focused on developing solutions that address cardiac and vascular surgeons’ challenges in treating patients with aortic diseases. The Company is engaged in the manufacturing, processing, and distribution of medical devices and implantable human tissues used in cardiac and vascular surgical procedures for patients with aortic disease. It has four major product families: aortic stent grafts, surgical sealants, On-X mechanical heart valves and related surgical products, and implantable cardiac and vascular human tissues. Its Medical Devices segment includes sales of aortic stent grafts, surgical sealants, On-X products, and other product revenues. Its Preservation Services segment includes services for the preservation of cardiac and vascular implantable human tissues. Aortic stent grafts include aortic arch stent grafts, abdominal stent grafts, and synthetic vascular grafts. Surgical sealants include its BioGlue Surgical Adhesive products.

Informações de Artivion Inc

Código da empresaAORT
Nome da EmpresaArtivion Inc
Data de listagemFeb 12, 1993
CEOMackin (James Patrick)
Número de funcionários1600
Tipo de títulosOrdinary Share
Fim do ano fiscalFeb 12
Endereço1655 Roberts Boulevard N W
CidadeKENNESAW
Bolsa de valoresNASDAQ OMX NASDAQ Basic NYSE
PaísUnited States of America
Código postal30144
Telefone17704193355
Sitehttps://artivion.com/
Código da empresaAORT
Data de listagemFeb 12, 1993
CEOMackin (James Patrick)

Executivos da empresa Artivion Inc

Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. John E. Davis
Mr. John E. Davis
Senior Vice President - Global Sales and Marketing
Senior Vice President - Global Sales and Marketing
203.01K
+7.32%
Mr. Lance A. Berry, CPA
Mr. Lance A. Berry, CPA
Chief Financial Officer, Chief Operating Officer, Executive Vice President - Finance, Treasurer
Chief Financial Officer, Chief Operating Officer, Executive Vice President - Finance, Treasurer
167.55K
+10.84%
Mr. Daniel J. Bevevino
Mr. Daniel J. Bevevino
Independent Director
Independent Director
157.64K
+4.81%
Mr. Thomas F. Ackerman
Mr. Thomas F. Ackerman
Independent Director
Independent Director
157.47K
+4.81%
Mr. Jon W. Salveson
Mr. Jon W. Salveson
Independent Director
Independent Director
137.42K
+5.51%
Ms. Amy D. Horton, CPA
Ms. Amy D. Horton, CPA
Chief Accounting Officer, Vice President
Chief Accounting Officer, Vice President
134.82K
+4.40%
Mr. James W. Bullock
Mr. James W. Bullock
Independent Director
Independent Director
76.22K
+9.94%
Mr. Jeffrey H. (Jeff) Burbank
Mr. Jeffrey H. (Jeff) Burbank
Lead Independent Director
Lead Independent Director
61.37K
+12.34%
Mr. Andrew M. Green
Mr. Andrew M. Green
Vice President - Regulatory Affairs
Vice President - Regulatory Affairs
60.26K
+44.40%
Dr. Marshall S. Stanton, M.D.
Dr. Marshall S. Stanton, M.D.
Senior Vice President, Clinical Research and Chief Medical Officer
Senior Vice President, Clinical Research and Chief Medical Officer
39.13K
+34.61%
Ver Mais
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. John E. Davis
Mr. John E. Davis
Senior Vice President - Global Sales and Marketing
Senior Vice President - Global Sales and Marketing
203.01K
+7.32%
Mr. Lance A. Berry, CPA
Mr. Lance A. Berry, CPA
Chief Financial Officer, Chief Operating Officer, Executive Vice President - Finance, Treasurer
Chief Financial Officer, Chief Operating Officer, Executive Vice President - Finance, Treasurer
167.55K
+10.84%
Mr. Daniel J. Bevevino
Mr. Daniel J. Bevevino
Independent Director
Independent Director
157.64K
+4.81%
Mr. Thomas F. Ackerman
Mr. Thomas F. Ackerman
Independent Director
Independent Director
157.47K
+4.81%
Mr. Jon W. Salveson
Mr. Jon W. Salveson
Independent Director
Independent Director
137.42K
+5.51%
Ms. Amy D. Horton, CPA
Ms. Amy D. Horton, CPA
Chief Accounting Officer, Vice President
Chief Accounting Officer, Vice President
134.82K
+4.40%

Perguntas frequentes

Quem são os cinco principais acionistas de Artivion Inc?

Os cinco principais acionistas de Artivion Inc são: Mr. John E. Davis

Quantas instituições possuem ações da Artivion Inc (AORT)?

Em 2026Q1, 449 instituições possuíam ações da Artivion Inc, com valor de mercado aproximado de 45.29M, representando 93.40% do total de ações. Em comparação com 2025Q4, a participação institucional aumentou em 501666.00.

Qual é a maior fonte de receita da Artivion Inc?

Em 2026Q1, o segmento de negócios Aortic stent grafts gerou a maior receita para Artivion Inc, totalizando 159.37M e representando 36.11% da receita total.